Sign in to view content

96-Week Visual and Expanded Anatomical Outcomes of Brolucizumab Versus Aflibercept in Patients With nAMD: Results From HAWK and HARRIER

Chirag D. Jhaveri, MD, FASRS

Video
Published 2019

Chirag D. Jhaveri, MD

AMD Neovascular Part I Symposium

Related

Retinal Vascular Disease Take-Home Panel
Neil M. Bressler, MD
Annual Meeting Talks
2019
The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019
Episode 4: 3-year Results of the TREX-AMD Trial with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017

Category: AMD-Neovascular

See more